Hyperglycemia in Critical Illness (A Review)

ABSTRACT

David Brealey, MB BS, BSc, Ph.D., FRCA, MRCP, and Mervyn Singer, MB BS, M.D., FRCP(Lon), FRCP(Edin)

Hyperglycemia is commonplace in the critically ill patient and is associated with worse outcomes. It occurs after severe stress (e.g., infection or injury) and results from a combination of increased secretion of catabolic hormones, increased hepatic gluconeogenesis, and resistance to the peripheral and hepatic actions of insulin. The use of carbohydrate-based feeds, glucose containing solutions, and drugs such as epinephrine may exacerbate the hyperglycemia. Mechanisms by which hyperglycemia cause harm are uncertain. Deranged osmolality and blood flow, intracellular acidosis, and enhanced superoxide production have all been implicated. The net result is derangement of endothelial, immune and coagulation function and an association with neuropathy and myopathy. These changes can be prevented, at least in part, by the use of insulin to maintain normoglycemia (J Diabetes Sci Technol 2009;3(6):1250-1260). 

Full Text: CLICK HERE